Skip to main content

Table 2 Multivariate Logistic Regression Analysis of Clinical characteristics associated with respiratory viruses

From: Epidemiological and clinical characteristics of respiratory viruses in 4403 pediatric patients from multiple hospitals in Guangdong, China

 

IFA

 

IFB

 

ADV

 

RSV

 

PIV1

 

PIV2

PIV3

 
 

OR(95 %CI)

P

OR(95 %CI)

P

OR(95 %CI)

P

OR(95 %CI)

P

OR(95 %CI)

P

P

OR(95 %CI)

P

Sex

 

NS

 

NS

 

NS

 

NS

 

NS

NS

 

NS

Age groups

  (0–6)mo

 

NS

0.049

(0.010–0.235)

0.000

 

NS

 

NS

 

NS

NS

 

NS

  (6–12)mo

 

NS

0.043

(0.010–0.186)

0.000

 

NS

 

NS

 

NS

NS

 

NS

  (1–2)yr

 

NS

0.016

(0.002–0.149)

0.000

 

NS

 

NS

 

NS

NS

 

NS

  (2–6)yr

 

NS

0.176

(0.056–0.552)

0.003

 

NS

 

NS

 

NS

NS

 

NS

  (6–12)yr

 

NS

0.205

(0.060–0.697)

0.011

 

NS

 

NS

 

NS

NS

 

NS

  (12–18)yr

 

NS

-a

  

NS

 

NS

 

NS

NS

 

NS

Clinical Symptoms

  

  Cyanosis

 

NS

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Fever

3.847

(1.836–8.061)

0.000

 

NS

1.635

(1.006–2.659)

0.047

 

NS

0.305

(0.167–0.556)

0.000

NS

0.550

(0.351–0.863)

0.009

  Shivering

2.733

(1.173–6.366)

0.020

 

NS

3.251

(1.514–6.981)

0.002

 

NS

 

NS

NS

 

NS

  Nasal congestion

2.314

(1.200-4.461)

0.012

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Nasal discharge

 

NS

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Sore throat

 

NS

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Cough

 

NS

 

NS

 

NS

2.152

(1.399–3.308)

0.000

 

NS

NS

 

NS

  Chest tightness

 

NS

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Shortness of breath

 

NS

 

NS

2.838

(1.497–5.38)

0.001

 

NS

 

NS

NS

 

NS

  Nausea

 

NS

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Abdominal pain

2.809

(1.126–7.011)

0.027

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  Neurological

symptoms

3.642

(1.450–9.145)

0.006

 

NS

 

NS

 

NS

 

NS

NS

 

NS

  1. Note: For each virus, an independent multivariate regression analysis was performed (i.e. whatever the virological result, positive or negative)
  2. a: Reference group; NS no significant.